A Study of NBL-028 in Patients With Advanced Solid Tumors

Clinical trial NCT06223256 · RECRUITING

Trial details

NCT number: NCT06223256
Sponsor: NovaRock Biotherapeutics, Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-03-08
Primary completion: 2027-01-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.